Abstract
In Brief Mariotti et al. demonstrated that radiofrequency ablation is more cost-effective, achieves a higher complete response rate, and has a lower complication rate than percutaneous ethanol injection in patients with early-stage hepatocellular carcinoma. Highlights Radiofrequency ablation and percutaneous ethanol injection are neoadjuvant hepatocellular carcinoma treatment methods. Radiofrequency ablation achieves a higher complete response rate (96.3% versus 60.0%, p=0.001). Total cost analyses showed radiofrequency ablation as a more expensive method (p<0.001). The incremental cost-effectiveness ratio was US$ -2674.59 with

This publication has 14 references indexed in Scilit: